Top Industry Leaders in the Type 2 Diabetes Mellitus Treatment Market
Latest Type 2 Diabetes Mellitus Treatment Companies Update
Eli Lilly Announced positive Phase 3 trial results for its GLP-1 receptor agonist Tirzepatide, demonstrating superior blood sugar control and weight loss compared to existing drugs.
Novo Nordisk Received FDA approval for its dual SGLT2/GLP-1 agonist Ozempic®, offering a new option for patients with inadequate glycemic control on other medications.
Boehringer Ingelheim Partnered with Eli Lilly to co-develop and commercialize their next-generation SGLT2 inhibitor Jardiance®, aiming to expand their reach in the diabetes market.
List of Type 2 Diabetes Mellitus Treatment Key Companies in the Market
- Abbott Laboratories
- Acon Laboratories Inc.
- Adocia
- Akros Pharma
- Amgen
- AstraZeneca
- Bayer AG
- Becton
- Dickinson and Company
- Biocon
- Boehringer Ingelheim
- Daiichi Sankyo
- Eli Lilly
- Merck
- Novartis & Co.
- Novo Nordisk
- Peptron
- Pfizer
- Roche Diagnostics Ltd.
- Sanofi
- Sunpharma
- Takeda Pharmaceuticals